ResMed Inc. Shares Soar on Strong Q3 Earnings and Strategic Growth Plans
ResMed Inc.’s shares surged 5.39% to €199.50 after the company reported an 8% increase in Q3 revenue, driven by strong demand for its sleep health products and strategic initiatives aimed at enhancing shareholder value.
2 minutes to read